about
In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cellsTenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?In situ mass spectrometry imaging and ex vivo characterization of renal crystalline deposits induced in multiple preclinical drug toxicology studiesRole of Oxidative Stress in Drug-Induced Kidney InjuryA Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 InfectionMultiphoton imaging reveals differences in mitochondrial function between nephron segments.HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.Antiviral selection in the management of acute retinal necrosis.Vitamin D deficiency aggravates nephrotoxicity, hypertension and dyslipidemia caused by tenofovir: role of oxidative stress and renin-angiotensin system.Proteomic characterization of acyclovir-induced nephrotoxicity in a mouse model.Accidental and iatrogenic causes of acute kidney injury.NLRP3 inflammasome mediates albumin-induced renal tubular injury through impaired mitochondrial function.Coblation plus photodynamic therapy (PDT) for the treatment of juvenile onset laryngeal papillomatosis: case reportsCurrent status of antiviral therapy for hepatitis BEfficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B.Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handlingType I interferon pathway mediates renal ischemia/reperfusion injury.Drug-associated renal dysfunction and injury.Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infectionsPredictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis BUpdate of acute kidney injury: intensive care nephrology.Biopsychronology: live confocal imaging of biopsies to assess organ function.Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.Treatment of hepatitis B in decompensated liver cirrhosis.Systematic Literature Review and Meta-Analysis of Renal Function in Human Immunodeficiency Virus (HIV)-Infected Patients Treated with Atazanavir (ATV)-Based Regimens.Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsAntitumor agents. 289. Design, synthesis, and anti-breast cancer activity in vivo of 4-amino-2H-benzo[h]chromen-2-one and 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogues with improved water solubility.Renal replacement therapy in ICUImpact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis BComparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients.Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.Comparing the effect of diode laser against acyclovir cream for the treatment of herpes labialisThe impact of impaired kidney function and HIV infection on the risk of anemia.Management of respiratory viral infections in hematopoietic cell transplant recipients.HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.Antivirals for the treatment of polyomavirus BK replication.Contrast-induced nephropathy following angiography and cardiac interventionsDrug interactions in childhood cancer.
P2860
Q24674939-214ECFE5-A3FF-4FDC-AA09-D75B09D6107FQ26995852-BC836150-8F61-49C8-8353-43490642848BQ27314740-B3ACABBC-0637-43F3-B692-B114DC291051Q28074502-B94C406E-EB4B-4ABE-92AD-D9FF8B315089Q28552839-1EE95F14-EA60-4C68-A827-9AFDE5BBBC84Q30487962-C94572B4-B136-4E0F-8EE7-350F880207DCQ32183133-D17F1CB2-5AA3-43A2-A824-3F28A02627C3Q33644146-7CB3DBD2-BA87-406D-9DD0-BF4B6F0BD2EDQ33928535-68DD8844-B509-42F3-B801-55631E0215C1Q33940210-00B1EA5A-7D07-4AA8-BFDB-5475DDC5DCECQ33954859-EB1765FC-2A5C-4BB4-B0DF-94014F9844C4Q34139079-5824992F-BD5A-4255-B3F8-98F043E49137Q34203014-3B760478-A67A-4495-9451-796160B7D782Q34408879-2803FE13-F47E-4F33-9E3F-F5DFD1D2F0FCQ34409132-396A2582-112B-4B8E-BA5A-B30BD9B50ED3Q34452514-EA83A939-30B9-4D3B-8223-9A3DC10D3B1EQ34557372-5C9EE0AF-B591-478C-9DDF-4CF38CEBD5BDQ34560483-9E74A1BA-B206-4F97-A6D1-EDDBC1BE31F1Q34606754-E75C47AB-C395-49EF-9626-C6C40996BB89Q35078052-98666CD8-72F2-450A-9EF2-280CC22E6E78Q35115570-F2ADF5D5-8A23-4279-BDEA-4BC2F244ADFBQ35153489-E68F21CE-33F5-4AFB-8E2A-DC6F2481CC36Q35155913-359ADC71-6D5E-4801-A023-C58CB3F41372Q35164657-6CAD1696-E572-4858-A3C0-B4948A94E641Q35207784-141A1F3B-CFDE-47DF-BB95-718634A090CFQ35566732-E89092EC-9974-449D-B6D2-8A89BD0FA821Q35795744-5A90410F-733B-4D4D-8480-2510168D746DQ35850997-E4B960CA-3E74-45C6-8262-1C3C3FBBBB47Q36133522-3B9548D5-31B7-40A9-87E1-C522E834BC96Q36151245-034013B2-A613-41E5-8BCC-FD8A92540F77Q36264219-DE68FD6E-7B08-4F1C-BFEB-D83DFBF82286Q36407276-4B24A524-1E8B-4BB0-B082-7EF91676C1D3Q36411918-D6024DA5-5BCF-4910-BD24-9C1B610C83CEQ36419540-B81DD0B1-D649-4F5B-8E35-B048707949C3Q36439896-9D781DFE-4E37-40E7-899B-3B6E92232B63Q36451062-B1627328-BE49-452E-B4F0-A73E56176FF0Q36687721-CB089D01-3CC5-42EA-84E8-4A0C6371FD42Q36723806-5F048ED8-47CC-43CD-88A0-148A038E8E84Q36761998-13EFCE57-B722-4015-91AD-A6E6A3789891Q36898141-FE042A8A-5C41-4085-A958-064591718D5D
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antiviral drug-induced nephrotoxicity.
@ast
Antiviral drug-induced nephrotoxicity.
@en
type
label
Antiviral drug-induced nephrotoxicity.
@ast
Antiviral drug-induced nephrotoxicity.
@en
prefLabel
Antiviral drug-induced nephrotoxicity.
@ast
Antiviral drug-induced nephrotoxicity.
@en
P1476
Antiviral drug-induced nephrotoxicity.
@en
P2093
Gilbert Deray
Hassane Izzedine
P304
P356
10.1053/J.AJKD.2005.02.010
P577
2005-05-01T00:00:00Z